|

TER-2013 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Terremoto Biosciences Inc.1

Indications

  • Lung Squamous Cell Carcinoma1
  • Esophageal Squamous Cell Carcinoma1
  • Endometrial Cancer1
  • Head and Neck Squamous Cell Carcinoma1
  • Solid Tumor1

Orlando, Florida1 trial

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Florida Cancer Specialists - Lake Nona

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.